Danaher Corporation (DHR)
Largest Insider Buys in Sector
DHR Stock Price History Chart
DHR Stock Performance
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and …
Insider Activity of Danaher Corporation
Over the last 12 months, insiders at Danaher Corporation have bought $0 and sold $60.77M worth of Danaher Corporation stock.
On average, over the past 5 years, insiders at Danaher Corporation have bought $10.25M and sold $149.02M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100 shares for transaction amount of $24,789 was made by RALES MITCHELL P (Chairman of Exec. Committee) on 2022‑05‑16.
List of Insider Buy and Sell Transactions, Danaher Corporation
| 2024-08-26 | Sale | SVP, Human Resources | 952 0.0001% | $268.37 | $255,483 | +0.28% | ||
| 2024-08-01 | Sale | director | 3,928 0.0005% | $279.50 | $1.1M | -4.25% | ||
| 2024-08-01 | Sale | EVP & Chief Financial Officer | 16,172 0.0022% | $279.84 | $4.53M | -4.25% | ||
| 2024-07-31 | Sale | President & CEO | 9,007 0.0013% | $280.00 | $2.52M | 0.00% | ||
| 2024-07-25 | Sale | SVP - Corporate Development | 14,507 0.002% | $270.51 | $3.92M | -0.37% | ||
| 2024-07-25 | Sale | Senior Vice President - GC | 9,600 0.0014% | $275.16 | $2.64M | -0.37% | ||
| 2024-05-16 | Sale | President & CEO | 9,005 0.0012% | $265.00 | $2.39M | +0.61% | ||
| 2024-05-14 | Sale | President & CEO | 19,085 0.0025% | $255.00 | $4.87M | +2.77% | ||
| 2024-05-10 | Sale | EVP & Chief Financial Officer | 46,377 0.0063% | $253.05 | $11.74M | +5.06% | ||
| 2024-05-02 | Sale | director | 708 <0.0001% | $243.58 | $172,455 | +7.32% | ||
| 2024-04-25 | Sale | Executive Vice President | 22,433 0.003% | $250.46 | $5.62M | +7.66% | ||
| 2024-04-24 | Sale | President & CEO | 47,175 0.0063% | $249.22 | $11.76M | +5.67% | ||
| 2024-04-24 | Sale | Senior Vice President - GC | 4,000 0.0005% | $250.01 | $1M | +5.67% | ||
| 2024-02-26 | Sale | SVP - Corporate Development | 23,757 0.0032% | $252.00 | $5.99M | +1.40% | ||
| 2024-02-15 | Sale | director | 3,289 0.0005% | $251.15 | $826,032 | +2.37% | ||
| 2024-02-13 | Sale | SVP, Human Resources | 2,622 0.0003% | $242.67 | $636,290 | +5.50% | ||
| 2024-02-06 | Sale | director | 3,289 0.0005% | $248.32 | $816,724 | +2.39% | ||
| 2023-08-21 | Sale | SVP, Chief Science Officer | 590 <0.0001% | $250.54 | $147,819 | +8.18% | ||
| 2023-07-28 | Sale | SVP - Corporate Development | 11,213 0.0016% | $260.65 | $2.92M | +1.21% | ||
| 2023-07-28 | Sale | director | 10,190 0.0014% | $260.25 | $2.65M | +1.21% |
Insider Historical Profitability
| FILLER LINDA | director | 41149 0.0057% | $235.84 | 4 | 9 | +2.2% |
| EHRLICH DONALD J | director | 123203 0.0171% | $235.84 | 1 | 15 | +10.65% |
| Zerhouni Elias A. | director | 25139 0.0035% | $235.84 | 1 | 2 | +18.68% |
| SCHWIETERS JOHN T | director | 19380 0.0027% | $235.84 | 3 | 6 | +9.74% |
| RALES MITCHELL P | Chairman of Exec. Committee | 3256 0.0005% | $235.84 | 9 | 5 | +16.9% |
Institutional Investor Ownership
| The Vanguard Group | $15.01B | 8.12 | 60.11M | +7.44% | +$1.04B | 0.28 | |
| BlackRock | $12.41B | 6.71 | 49.68M | -2.15% | -$271.97M | 0.27 | |
| State Street | $6.94B | 3.75 | 27.76M | +0.91% | +$62.89M | 0.28 | |
| Wellington Management Company | $6.67B | 3.61 | 26.72M | -4.31% | -$300.56M | 1.13 | |
| Fidelity Investments | $5.55B | 3 | 22.22M | -0.59% | -$32.77M | 0.37 |